Proceedings from the 2nd Next Gen Therapies for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome symposium held on October 3-4, 2019

• Ngā kaituhi matua: Scott W. Canna (Author), Grant S. Schulert (Author), Adriana de Jesus (Author), Alex Pickering (Author), Hermine Brunner (Author), Massimo Gadina (Author), Stewart Levine (Author), Raphaela Goldbach-Mansky (Author), Jonathan Boutelle (Author), Rashmi Sinha (Author), Fabrizio DeBenedetti (Author), Alexei Grom (Author), on behalf of the NextGen 2019 Participants (Author)
• Hōputu: Pukapuka
• I whakaputaina: BMC, 2020-07-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Abstract For reasons poorly understood, and despite the availability of biological medications blocking IL-1 and IL-6 that have markedly improved overall disease control, children with Systemic Juvenile Idiopathic Arthritis (SJIA) are now increasingly diagnosed with life-threatening chronic complica...